Author:
Thomassen Yvonne E.,Rubingh Olaf,Wijffels René H.,van der Pol Leo A.,Bakker Wilfried A.M.
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine
Reference25 articles.
1. Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV;Bakker;Vaccine,2011
2. Next generation inactivated polio vaccine manufacturing to support post polio-eradication biosafety goals;Thomassen;PLoS ONE,2013
3. Scale-down of the inactivated polio vaccine production process;Thomassen;Biotechnol Bioeng,2013
4. Meeting of the strategic advisory group of experts on immunization. November 2012 – conclusions and recommendations;WHO;Wkly Epidemiol Rec,2013
5. Venczel L, Landry S, Aylward B, Sutter R, Sabow A, Smith G. Global post-eradication IPV supply and demand assessment: integrated findings commissioned by the Bill & Melinda Gates Foundation and prepared by Oliver Wyman Inc. Available online at: www.polioeradication.org. 2009, [accessed 16 September 2013].
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献